Raymond James Trust N.A. Gilead Sciences, Inc. Transaction History

Raymond James Trust N.A.

  • $4.55 Billion
  • Q3 2024

A detailed history of Raymond James Trust N.A. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Raymond James Trust N.A. holds 45,519 shares of GILD stock, worth $5.03 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
45,519
Previous 44,110 3.19%
Holding current value
$5.03 Million
Previous $3.03 Million 26.07%
% of portfolio
0.08%
Previous 0.07%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$66.59 - $83.99 $93,825 - $118,341
1,409 Added 3.19%
45,519 $3.82 Million
Q2 2024

Jul 25, 2024
BUY
$63.15 - $72.88 $153,012 - $176,588
2,423 Added 5.81%
44,110 $3.03 Million
Q1 2024

Apr 24, 2024
SELL
$71.58 - $87.29 $93,555 - $114,088
-1,307 Reduced 3.04%
41,687 $3.05 Million
Q4 2023

Jan 10, 2024
BUY
$73.27 - $83.09 $307,514 - $348,728
4,197 Added 10.82%
42,994 $3.48 Million
Q3 2023

Nov 14, 2023
BUY
$73.94 - $80.67 $139,894 - $152,627
1,892 Added 5.13%
38,797 $2.91 Million
Q2 2023

Aug 15, 2023
SELL
$76.01 - $86.7 $279,412 - $318,709
-3,676 Reduced 9.06%
36,905 $2.85 Million
Q1 2023

May 03, 2023
SELL
$77.31 - $88.08 $524,161 - $597,182
-6,780 Reduced 14.32%
40,581 $3.37 Million
Q4 2022

Feb 02, 2023
SELL
$62.32 - $89.47 $136,044 - $195,313
-2,183 Reduced 4.41%
47,361 $4.07 Million
Q3 2022

Oct 31, 2022
SELL
$59.54 - $68.01 $35,128 - $40,125
-590 Reduced 1.18%
49,544 $3.06 Million
Q2 2022

Jul 14, 2022
BUY
$57.72 - $65.01 $124,328 - $140,031
2,154 Added 4.49%
50,134 $3.1 Million
Q1 2022

May 12, 2022
BUY
$57.92 - $72.58 $114,507 - $143,490
1,977 Added 4.3%
47,980 $2.85 Million
Q4 2021

Jan 31, 2022
SELL
$64.88 - $73.64 $267,370 - $303,470
-4,121 Reduced 8.22%
46,003 $3.34 Million
Q3 2021

Oct 18, 2021
BUY
$67.69 - $73.03 $9,273 - $10,005
137 Added 0.27%
50,124 $3.5 Million
Q2 2021

Jul 20, 2021
SELL
$63.47 - $69.35 $4,887 - $5,339
-77 Reduced 0.15%
49,987 $3.44 Million
Q1 2021

May 03, 2021
BUY
$60.0 - $68.46 $13,500 - $15,403
225 Added 0.45%
50,064 $3.24 Million
Q4 2020

Jan 13, 2021
BUY
$56.65 - $64.55 $282,400 - $321,781
4,985 Added 11.11%
49,839 $2.9 Million
Q3 2020

Oct 14, 2020
BUY
$62.1 - $78.08 $537,040 - $675,235
8,648 Added 23.89%
44,854 $2.83 Million
Q2 2020

Jul 16, 2020
SELL
$72.34 - $84.0 $475,635 - $552,300
-6,575 Reduced 15.37%
36,206 $2.79 Million
Q1 2020

Apr 17, 2020
BUY
$62.63 - $80.22 $289,538 - $370,857
4,623 Added 12.12%
42,781 $3.2 Million
Q4 2019

Jan 14, 2020
SELL
$61.62 - $67.78 $8,811 - $9,692
-143 Reduced 0.37%
38,158 $2.48 Million
Q3 2019

Oct 24, 2019
BUY
$62.51 - $69.0 $1.09 Million - $1.21 Million
17,465 Added 83.82%
38,301 $2.43 Million
Q2 2019

Jul 15, 2019
SELL
$61.87 - $69.38 $112,479 - $126,132
-1,818 Reduced 8.03%
20,836 $1.41 Million
Q1 2019

Apr 15, 2019
SELL
$62.53 - $70.05 $77,099 - $86,371
-1,233 Reduced 5.16%
22,654 $1.47 Million
Q4 2018

Jan 29, 2019
SELL
$60.54 - $79.0 $35,234 - $45,978
-582 Reduced 2.38%
23,887 $1.49 Million
Q3 2018

Oct 16, 2018
BUY
$71.28 - $78.92 $124,454 - $137,794
1,746 Added 7.68%
24,469 $1.89 Million
Q2 2018

Jul 11, 2018
SELL
$64.88 - $75.68 $19,723 - $23,006
-304 Reduced 1.32%
22,723 $1.61 Million
Q1 2018

Apr 05, 2018
BUY
$72.84 - $88.8 $31,612 - $38,539
434 Added 1.92%
23,027 $1.74 Million
Q4 2017

Feb 02, 2018
SELL
$71.15 - $83.52 $270,227 - $317,208
-3,798 Reduced 14.39%
22,593 $1.62 Million
Q3 2017

Oct 24, 2017
BUY
$72.11 - $85.47 $55,164 - $65,384
765 Added 2.99%
26,391 $2.14 Million
Q2 2017

Aug 10, 2017
BUY
N/A
25,626
25,626 $1.81 Million

Others Institutions Holding GILD

# of Institutions
2,287
Shares Held
997M
Call Options Held
9.62M
Put Options Held
10M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $138B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Raymond James Trust N.A. Portfolio

Follow Raymond James Trust N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Trust N.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email